Related Experiment Video
Updated: Jul 18, 2026
04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
[Painless thyroiditis].
Ken Okamura1, Megumi Fujikawa, Sachiko Bandai
1Department of Health Sciences, School of Medicine, Kyushu University.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 13, 2006
Summary
Painless thyroiditis involves thyrotoxicosis without hyperthyroidism, driven by thyroglobulin hydrolysis. Differentiating it from Graves
Area of Science:
- Endocrinology
- Thyroidology
Background:
- Painless thyroiditis presents as painless low-uptake thyrotoxicosis, a condition where the thyroid gland is overactive without elevated thyroid hormone levels.
- Thyroid gland destruction was previously considered the primary cause of self-limited thyrotoxicosis.
Purpose of the Study:
- To investigate the mechanism of excessive thyroid hormone release in painless thyroiditis, specifically the uncoupling of hormone synthesis and secretion.
- To explore factors contributing to suppressed hormone synthesis, including TSH levels, cytokines (e.g., TGFbeta1), and thyroglobulin.
- To clarify the persistent hormone release mechanism despite suppressed synthesis.
Main Methods:
- Analysis of thyrotoxicosis characteristics, including iodine uptake and thyroid hormone levels.
- Evaluation of potential suppressors of thyroid hormone synthesis.
- Utilizing quantitative TSH binding inhibitor immunoglobulin assay for differential diagnosis.
Main Results:
- Hydrolysis of thyroglobulin is identified as the key mechanism for excessive thyroid hormone release.
- Low iodine uptake coupled with excessive hormone release indicates a dissociation between hormone synthesis and secretion.
- Suppressed serum TSH, TGFbeta1, and thyroglobulin are implicated in suppressed hormone synthesis.
Conclusions:
- Painless thyroiditis involves thyroglobulin hydrolysis leading to hormone release, uncoupled from synthesis.
- Further research is needed to elucidate the mechanism of persistent hormone release.
- Quantitative TSH binding inhibitor immunoglobulin assay aids in distinguishing painless thyroiditis from Graves' hyperthyroidism.
Related Concept Videos
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...